Published in Managed Care Business Week, June 23rd, 2009
Under the terms of the agreement, Amalyte will have exclusive rights to develop and commercialize collaboration products worldwide, except in Japan and several Asian countries where Meiji has a development and commercialization option for all products arising from the collaboration. The companies will co-market...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.